» Articles » PMID: 38543553

The Efficacy of Selected Probiotic Strains and Their Combination to Inhibit the Interaction of Adherent-Invasive (AIEC) with a Co-Culture of Caco-2:HT29-MTX Cells

Overview
Journal Microorganisms
Specialty Microbiology
Date 2024 Mar 28
PMID 38543553
Authors
Affiliations
Soon will be listed here.
Abstract

The gastrointestinal tract's microbiota plays a crucial role in human health, with dysbiosis linked to the development of diseases such as inflammatory bowel disease (IBD). Whilst the pathogenic mechanisms underlying IBD remain poorly characterised, adherent-invasive (AIEC) has been implicated as a microbiological factor in disease pathogenesis. These strains show an enhanced ability to diffusely adhere to and invade intestinal epithelial cells, along with the ability to survive and replicate within macrophages. Probiotics, such as strains, have been identified as potential treatment options due to their abilities to compete with pathogens for binding sites and regulate the host immune response. In this study, we used four well-characterised strains and their combination to test their ability to inhibit the adhesion, invasion, and translocation of a well-characterized AIEC strain, F44A-1, in a co-culture of Caco-2 and HT29-MTX cell lines representing the gut epithelium. The results demonstrated that the pre-inoculation of the probiotic candidates 90 min prior to the introduction of the AIEC was more effective in inhibiting AIEC interaction than the co-inoculation of the strains. While the individual probiotic strains greatly reduced AIEC colonisation and invasion of the co-cultured cells, their combination was only more effective in reducing the translocation of the AIEC. These results suggest that probiotics are more effective when used prophylactically against pathogens and that the combination of strains may enhance their efficacy against AIEC translocation once used as a prophylactic measure.

Citing Articles

Impact of Re-Du-Ning enema treatment on the intestinal microflora in pediatric patients with hand, foot, and mouth disease.

Tang K, Li M, Guo Q, Wang J, Lu H, Wang B Transl Pediatr. 2025; 13(12):2118-2133.

PMID: 39823009 PMC: 11732627. DOI: 10.21037/tp-24-257.


Beneficial and Safety Properties of a Bacteriocinogenic and Putative Probiotic subsp. 2a Strain.

Lipilkina T, Xu C, Barbosa M, Khramova V, Shebeko S, Ermakov A Foods. 2024; 13(23).

PMID: 39682842 PMC: 11640536. DOI: 10.3390/foods13233770.


The Impact of Bioactive Molecules from Probiotics on Child Health: A Comprehensive Review.

Guaman L, Carrera-Pacheco S, Zuniga-Miranda J, Teran E, Erazo C, Barba-Ostria C Nutrients. 2024; 16(21).

PMID: 39519539 PMC: 11547800. DOI: 10.3390/nu16213706.


Studies on the Probiotic, Adhesion, and Induction Properties of Artisanal Lactic Acid Bacteria: to Customize a Gastrointestinal Niche to Trigger Anti-obesity Functions.

Kamber A, Bulut Albayrak C, Harsa H Probiotics Antimicrob Proteins. 2024; .

PMID: 39382740 DOI: 10.1007/s12602-024-10357-6.


Environmental Influence on Bacterial Lipid Composition: Insights from Pathogenic and Probiotic Strains.

Walczak-Skierska J, Ludwiczak A, Sibinska E, Pomastowski P ACS Omega. 2024; 9(36):37789-37801.

PMID: 39281888 PMC: 11391446. DOI: 10.1021/acsomega.4c03778.


References
1.
Ghanavati R, Akbari A, Mohammadi F, Asadollahi P, Javadi A, Talebi M . Lactobacillus species inhibitory effect on colorectal cancer progression through modulating the Wnt/β-catenin signaling pathway. Mol Cell Biochem. 2020; 470(1-2):1-13. DOI: 10.1007/s11010-020-03740-8. View

2.
Kajander K, Korpela R . Clinical studies on alleviating the symptoms of irritable bowel syndrome. Asia Pac J Clin Nutr. 2006; 15(4):576-80. View

3.
Aghamohammad S, Sepehr A, Miri S, Najafi S, Pourshafie M, Rohani M . Anti-inflammatory and immunomodulatory effects of Lactobacillus spp. as a preservative and therapeutic agent for IBD control. Immun Inflamm Dis. 2022; 10(6):e635. PMC: 9119005. DOI: 10.1002/iid3.635. View

4.
Manichanh C, Borruel N, Casellas F, Guarner F . The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012; 9(10):599-608. DOI: 10.1038/nrgastro.2012.152. View

5.
Ramos N, Lamprokostopoulou A, Chapman T, Chin J, Romling U, Brauner A . Virulence characteristics of translocating Escherichia coli and the interleukin-8 response to infection. Microb Pathog. 2010; 50(2):81-6. DOI: 10.1016/j.micpath.2010.11.003. View